| SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ... Nature communications 11 (1), 5064, 2020 | 323 | 2020 |
| The human secretome M Uhlén, MJ Karlsson, A Hober, AS Svensson, J Scheffel, D Kotol, ... Science signaling 12 (609), eaaz0274, 2019 | 314 | 2019 |
| The role of proteomics in prostate cancer research: biomarker discovery and validation E Pin, C Fredolini, EF Petricoin III Clinical biochemistry 46 (6), 524-538, 2013 | 91 | 2013 |
| Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort R Carapito, R Li, J Helms, C Carapito, S Gujja, V Rolli, R Guimaraes, ... Science translational medicine 14 (628), eabj7521, 2022 | 85 | 2022 |
| Multiplexed analysis of the secretin-like GPCR-RAMP interactome E Lorenzen, T Dodig-Crnković, IB Kotliar, E Pin, E Ceraudo, RD Vaughan, ... Science advances 5 (9), eaaw2778, 2019 | 67 | 2019 |
| Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19 S Havervall, H Ng, A Jernbom Falk, N Greilert‐Norin, A Månberg, ... Journal of internal medicine 291 (1), 72-80, 2022 | 59 | 2022 |
| HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer CH Lai, KS Park, DH Lee, AT Alberobello, M Raffeld, M Pierobon, E Pin, ... Oncogene 33 (40), 4867-4876, 2014 | 56 | 2014 |
| MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p. Tyr179Cys and p. Gly396Asp by founder events S Aretz, R Tricarico, L Papi, I Spier, E Pin, S Horpaopan, EL Cordisco, ... European Journal of Human Genetics 22 (7), 923-929, 2014 | 51 | 2014 |
| Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood–brain barrier disruption and outcome prediction following severe traumatic brain injury … C Lindblad, E Pin, D Just, F Al Nimer, P Nilsson, BM Bellander, ... Critical Care 25, 1-18, 2021 | 49 | 2021 |
| Loss of MUTYH function in human cells leads to accumulation of oxidative damage and genetic instability V Ruggieri, E Pin, MT Russo, F Barone, P Degan, M Sanchez, M Quaia, ... Oncogene 32 (38), 4500-4508, 2013 | 49 | 2013 |
| Immunocapture strategies in translational proteomics C Fredolini, S Byström, E Pin, F Edfors, D Tamburro, MJ Iglesias, ... Expert review of proteomics 13 (1), 83-98, 2016 | 47 | 2016 |
| Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2 S Havervall, U Marking, N Greilert-Norin, H Ng, M Gordon, ... EBioMedicine 70, 2021 | 46 | 2021 |
| Integrated analysis of unclassified variants in mismatch repair genes C Pastrello, E Pin, F Marroni, C Bedin, M Fornasarig, MG Tibiletti, C Oliani, ... Genetics in Medicine 13 (2), 115-124, 2011 | 45 | 2011 |
| Preparation and use of reverse protein microarrays E Pin, G Federici, EF Petricoin III Current protocols in protein science 75 (1), 27.7. 1-27.7. 29, 2014 | 44 | 2014 |
| SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection S Havervall, A Jernbom Falk, J Klingström, H Ng, N Greilert-Norin, ... PloS One 17 (1), e0262169, 2022 | 43 | 2022 |
| Individualized therapy for metastatic colorectal cancer A Silvestri, E Pin, A Huijbers, R Pellicani, EM Parasido, M Pierobon, ... Journal of internal medicine 274 (1), 1-24, 2013 | 43 | 2013 |
| Persisting salivary IgG against SARS-CoV-2 at 9 months after mild COVID-19: a complementary approach to population surveys H Alkharaan, S Bayati, C Hellström, S Aleman, A Olsson, K Lindahl, ... The Journal of Infectious Diseases 224 (3), 407-414, 2021 | 40 | 2021 |
| Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to … M Pierobon, A Silvestri, A Spira, A Reeder, E Pin, S Banks, E Parasido, ... Journal of proteome research 13 (6), 2846-2855, 2014 | 36 | 2014 |
| Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B-and T-cell immunity during 13 months in consecutive patients L Blixt, G Bogdanovic, M Buggert, Y Gao, S Hober, K Healy, H Johansson, ... Leukemia 36 (2), 476-481, 2022 | 35 | 2022 |
| Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis KA Högelin, N Ruffin, E Pin, A Månberg, S Hober, G Gafvelin, H Grönlund, ... Iscience 24 (9), 2021 | 34 | 2021 |
